

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.82573257 |
| 2 | chondrocyte proliferation (GO:0035988) | 6.39552616 |
| 3 | skin morphogenesis (GO:0043589) | 6.34010393 |
| 4 | negative regulation of leukocyte chemotaxis (GO:0002689) | 5.57734759 |
| 5 | wound healing, spreading of epidermal cells (GO:0035313) | 5.45392928 |
| 6 | cell adhesion mediated by integrin (GO:0033627) | 5.38357030 |
| 7 | regulation of vitamin metabolic process (GO:0030656) | 5.32646602 |
| 8 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.26169351 |
| 9 | collagen fibril organization (GO:0030199) | 5.20183841 |
| 10 | mesenchymal-epithelial cell signaling (GO:0060638) | 5.14527737 |
| 11 | response to peptidoglycan (GO:0032494) | 4.99353344 |
| 12 | positive regulation of chemokine secretion (GO:0090197) | 4.71320115 |
| 13 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.68992985 |
| 14 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.63433723 |
| 15 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 4.63059247 |
| 16 | regulation of chemokine secretion (GO:0090196) | 4.62270431 |
| 17 | regulation of chronic inflammatory response (GO:0002676) | 4.61869063 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.60215212 |
| 19 | regulation of heat generation (GO:0031650) | 4.56961087 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.56652077 |
| 21 | regulation of chemokine biosynthetic process (GO:0045073) | 4.47039279 |
| 22 | negative regulation of fatty acid transport (GO:2000192) | 4.38517245 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.33184163 |
| 24 | wound healing, spreading of cells (GO:0044319) | 4.29786502 |
| 25 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.29420061 |
| 26 | regulation of monocyte chemotaxis (GO:0090025) | 4.26106421 |
| 27 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.24372029 |
| 28 | endodermal cell differentiation (GO:0035987) | 4.20133266 |
| 29 | cellular response to ATP (GO:0071318) | 4.19628781 |
| 30 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.19582471 |
| 31 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 4.19548189 |
| 32 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.16317186 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 4.04022425 |
| 34 | regulation of podosome assembly (GO:0071801) | 4.03655206 |
| 35 | positive regulation of macrophage activation (GO:0043032) | 4.02391918 |
| 36 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.99497483 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.90768951 |
| 38 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.90100938 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.84644374 |
| 40 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.84102571 |
| 41 | mesodermal cell differentiation (GO:0048333) | 3.83915196 |
| 42 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.73933949 |
| 43 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.68685525 |
| 44 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.65035294 |
| 45 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.58745920 |
| 46 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.58442600 |
| 47 | decidualization (GO:0046697) | 3.58006973 |
| 48 | cellular response to exogenous dsRNA (GO:0071360) | 3.56447009 |
| 49 | granulocyte activation (GO:0036230) | 3.56024257 |
| 50 | regulation of pigment cell differentiation (GO:0050932) | 3.53083252 |
| 51 | desmosome organization (GO:0002934) | 3.53027453 |
| 52 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.50262059 |
| 53 | regulation of mononuclear cell migration (GO:0071675) | 3.50096385 |
| 54 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.49975638 |
| 55 | positive regulation of osteoblast proliferation (GO:0033690) | 3.48391548 |
| 56 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.45301897 |
| 57 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.44338304 |
| 58 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.43653415 |
| 59 | response to protozoan (GO:0001562) | 3.43307954 |
| 60 | cellular response to vitamin D (GO:0071305) | 3.41898069 |
| 61 | T-helper 1 type immune response (GO:0042088) | 3.41047715 |
| 62 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.40434701 |
| 63 | regulation of growth of symbiont in host (GO:0044126) | 3.40434701 |
| 64 | negative regulation of growth of symbiont in host (GO:0044130) | 3.40434701 |
| 65 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.40434701 |
| 66 | protein localization to cell surface (GO:0034394) | 3.39551337 |
| 67 | axon extension involved in axon guidance (GO:0048846) | 3.39366575 |
| 68 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.39366575 |
| 69 | positive regulation of interleukin-17 production (GO:0032740) | 3.37382006 |
| 70 | regulation of fever generation (GO:0031620) | 3.37156169 |
| 71 | regulation of myeloid cell apoptotic process (GO:0033032) | 3.33082399 |
| 72 | hemidesmosome assembly (GO:0031581) | 3.32184918 |
| 73 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.31372479 |
| 74 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.29637406 |
| 75 | positive regulation of heat generation (GO:0031652) | 3.27908690 |
| 76 | cyclooxygenase pathway (GO:0019371) | 3.25715881 |
| 77 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.25527672 |
| 78 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.25433379 |
| 79 | neutrophil activation (GO:0042119) | 3.24978685 |
| 80 | natural killer cell activation involved in immune response (GO:0002323) | 3.24753566 |
| 81 | * positive regulation of interleukin-6 production (GO:0032755) | 3.23163019 |
| 82 | response to muramyl dipeptide (GO:0032495) | 3.20731710 |
| 83 | hepatocyte differentiation (GO:0070365) | 3.20471678 |
| 84 | protein heterotrimerization (GO:0070208) | 3.20014960 |
| 85 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.19054681 |
| 86 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.18482398 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.17547857 |
| 88 | hair cycle (GO:0042633) | 3.16494525 |
| 89 | molting cycle (GO:0042303) | 3.16494525 |
| 90 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.16406116 |
| 91 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.15546204 |
| 92 | negative regulation of lipid storage (GO:0010888) | 3.14410511 |
| 93 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.14122178 |
| 94 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.13285215 |
| 95 | regulation of T-helper cell differentiation (GO:0045622) | 3.12118336 |
| 96 | response to ATP (GO:0033198) | 3.11941286 |
| 97 | peptide cross-linking (GO:0018149) | 3.09593615 |
| 98 | positive regulation of developmental pigmentation (GO:0048087) | 3.06937062 |
| 99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.06350020 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05217723 |
| 101 | plasma membrane repair (GO:0001778) | 3.05203786 |
| 102 | negative regulation of cytokine secretion (GO:0050710) | 3.04910136 |
| 103 | chronic inflammatory response (GO:0002544) | 3.04693521 |
| 104 | prostaglandin biosynthetic process (GO:0001516) | 3.04224194 |
| 105 | prostanoid biosynthetic process (GO:0046457) | 3.04224194 |
| 106 | apoptotic cell clearance (GO:0043277) | 3.03305883 |
| 107 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.01167126 |
| 108 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.99061495 |
| 109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98931394 |
| 110 | defense response to protozoan (GO:0042832) | 2.97725832 |
| 111 | cellular response to lipopolysaccharide (GO:0071222) | 2.96041552 |
| 112 | response to manganese ion (GO:0010042) | 2.95156750 |
| 113 | cellular response to interferon-alpha (GO:0035457) | 2.94305549 |
| 114 | response to vitamin D (GO:0033280) | 2.94136496 |
| 115 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.92580561 |
| 116 | negative regulation of interleukin-8 production (GO:0032717) | 2.91976173 |
| 117 | cell-substrate junction assembly (GO:0007044) | 2.91656807 |
| 118 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.91020598 |
| 119 | positive regulation of acute inflammatory response (GO:0002675) | 2.88905175 |
| 120 | substrate-dependent cell migration (GO:0006929) | 2.88902276 |
| 121 | positive regulation of natural killer cell activation (GO:0032816) | 2.88700682 |
| 122 | epithelial cell-cell adhesion (GO:0090136) | 2.88598636 |
| 123 | cellular response to vitamin (GO:0071295) | 2.88498705 |
| 124 | positive regulation of interleukin-12 production (GO:0032735) | 2.88097113 |
| 125 | cellular response to nicotine (GO:0071316) | 2.87937088 |
| 126 | craniofacial suture morphogenesis (GO:0097094) | 2.87843530 |
| 127 | blood vessel endothelial cell migration (GO:0043534) | 2.87541553 |
| 128 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.87334351 |
| 129 | collagen metabolic process (GO:0032963) | 2.86145685 |
| 130 | regulation of interleukin-12 production (GO:0032655) | 2.85116353 |
| 131 | extracellular matrix disassembly (GO:0022617) | 2.84283156 |
| 132 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84220396 |
| 133 | dermatan sulfate biosynthetic process (GO:0030208) | 2.83444504 |
| 134 | regulation of interleukin-17 production (GO:0032660) | 2.83264743 |
| 135 | response to exogenous dsRNA (GO:0043330) | 2.82146210 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.81648529 |
| 137 | positive regulation of protein autophosphorylation (GO:0031954) | 2.80943163 |
| 138 | regulation of water loss via skin (GO:0033561) | 2.80577009 |
| 139 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80464288 |
| 140 | regulation of prostaglandin secretion (GO:0032306) | 2.80323849 |
| 141 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.79555264 |
| 142 | cranial suture morphogenesis (GO:0060363) | 2.79488122 |
| 143 | germinal center formation (GO:0002467) | 2.78997007 |
| 144 | * keratinocyte differentiation (GO:0030216) | 2.78879961 |
| 145 | natural killer cell mediated immunity (GO:0002228) | 2.78578699 |
| 146 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.78578699 |
| 147 | regulation of histone phosphorylation (GO:0033127) | 2.78177482 |
| 148 | regulation of plasminogen activation (GO:0010755) | 2.78054053 |
| 149 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.77972285 |
| 150 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.77123188 |
| 151 | positive regulation of defense response to virus by host (GO:0002230) | 2.76625760 |
| 152 | positive regulation of chemokine production (GO:0032722) | 2.75514832 |
| 153 | collagen catabolic process (GO:0030574) | 2.74317193 |
| 154 | establishment of endothelial barrier (GO:0061028) | 2.73805504 |
| 155 | regulation of transforming growth factor beta production (GO:0071634) | 2.72905488 |
| 156 | endocardial cushion development (GO:0003197) | 2.72887223 |
| 157 | neutrophil mediated immunity (GO:0002446) | 2.72071119 |
| 158 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.69998753 |
| 159 | oligosaccharide catabolic process (GO:0009313) | 2.69620542 |
| 160 | lymphangiogenesis (GO:0001946) | 2.69377787 |
| 161 | negative regulation of interleukin-17 production (GO:0032700) | 2.68779676 |
| 162 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.66965401 |
| 163 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.66965401 |
| 164 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.66961161 |
| 165 | hippo signaling (GO:0035329) | 2.66690178 |
| 166 | positive regulation of astrocyte differentiation (GO:0048711) | 2.65976824 |
| 167 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.65375064 |
| 168 | positive regulation of macrophage differentiation (GO:0045651) | 2.65263066 |
| 169 | establishment of skin barrier (GO:0061436) | 2.64377957 |
| 170 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.64099458 |
| 171 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63613845 |
| 172 | negative regulation of biomineral tissue development (GO:0070168) | 2.63016459 |
| 173 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.62919879 |
| 174 | regulation of interleukin-8 secretion (GO:2000482) | 2.62804363 |
| 175 | response to dsRNA (GO:0043331) | 2.62272447 |
| 176 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60939842 |
| 177 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60615536 |
| 178 | regulation of immunoglobulin secretion (GO:0051023) | 2.60003428 |
| 179 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.58892420 |
| 180 | regulation of response to interferon-gamma (GO:0060330) | 2.58837937 |
| 181 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.58685096 |
| 182 | positive regulation of interleukin-10 production (GO:0032733) | 2.57954394 |
| 183 | * regulation of interleukin-6 production (GO:0032675) | 2.57448081 |
| 184 | regulation of macrophage chemotaxis (GO:0010758) | 2.57152987 |
| 185 | dermatan sulfate metabolic process (GO:0030205) | 2.56646361 |
| 186 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.54745962 |
| 187 | regulation of osteoblast proliferation (GO:0033688) | 2.54539181 |
| 188 | stress fiber assembly (GO:0043149) | 2.54403239 |
| 189 | positive regulation of epithelial cell migration (GO:0010634) | 2.53325821 |
| 190 | multicellular organismal metabolic process (GO:0044236) | 2.53051630 |
| 191 | regulation of macrophage cytokine production (GO:0010935) | 2.53050320 |
| 192 | multicellular organismal catabolic process (GO:0044243) | 2.52835514 |
| 193 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.52394233 |
| 194 | * wound healing (GO:0042060) | 2.51700759 |
| 195 | prostanoid metabolic process (GO:0006692) | 2.50554288 |
| 196 | prostaglandin metabolic process (GO:0006693) | 2.50554288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.50954137 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.65660951 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.71489102 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53320957 |
| 5 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.99096116 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.86998586 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24231572 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.04880572 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.98671008 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91219499 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77375074 |
| 12 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.75300967 |
| 13 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.75300967 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72104435 |
| 15 | CJUN_26792858_Chip-Seq_BT549_Human | 2.65144820 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.48741314 |
| 17 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.47025678 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46067191 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43414152 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.37951262 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.36628596 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35943804 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.34156107 |
| 24 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.33343385 |
| 25 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.33343385 |
| 26 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.32726260 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32640623 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.23923140 |
| 29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.22145882 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20281575 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12713105 |
| 32 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.05652899 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.02283647 |
| 34 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.99439628 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.97536175 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94971419 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.92774261 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.89052061 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89040962 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.87630736 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87553574 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87352544 |
| 43 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.78977593 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.78235110 |
| 45 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.74059801 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.73991838 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.72660237 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70422225 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63150804 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.62554639 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62247906 |
| 52 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61902548 |
| 53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.61609405 |
| 54 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.60316376 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57792458 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55186042 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54168582 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52434180 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49501445 |
| 60 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48494640 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48130197 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47377322 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.45430957 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.44810285 |
| 65 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.43389640 |
| 66 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.43389640 |
| 67 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.43389640 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42538667 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40953174 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39479543 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38077138 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33014277 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32399823 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31743370 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30458065 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30175854 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27417023 |
| 78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24509246 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22887496 |
| 80 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.22641716 |
| 81 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.22567572 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22520887 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22142355 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19558700 |
| 85 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17335481 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17099012 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17036140 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16834154 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16669850 |
| 90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14351776 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13898348 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13301242 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12139903 |
| 94 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11639889 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10742602 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10509683 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10114421 |
| 98 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08215380 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06550394 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06206595 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05729740 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05108656 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02329195 |
| 104 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00944416 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00725539 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00280715 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00032179 |
| 108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99325791 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98399020 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 0.97394764 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96753644 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96666029 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96635039 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96469473 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95540621 |
| 116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94809266 |
| 117 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94452187 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94107074 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92959329 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90355477 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90177423 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90096036 |
| 123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89991974 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88904289 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87305307 |
| 126 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.86951907 |
| 127 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.86448921 |
| 128 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86264068 |
| 129 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86252923 |
| 130 | * NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.85562286 |
| 131 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84743166 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84003222 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83744117 |
| 134 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82859662 |
| 135 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82279797 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81911503 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81624817 |
| 138 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.79704693 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79233511 |
| 140 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.78541226 |
| 141 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77633982 |
| 142 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76190250 |
| 143 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74682472 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74096309 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.73274183 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70953821 |
| 147 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.70187461 |
| 148 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69363055 |
| 149 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69304002 |
| 150 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.67205770 |
| 151 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.66685813 |
| 152 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.66178155 |
| 153 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.65648039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.04149451 |
| 2 | MP0005275_abnormal_skin_tensile | 5.21203614 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.05188323 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 3.97333948 |
| 5 | MP0008004_abnormal_stomach_pH | 2.96315561 |
| 6 | MP0009785_altered_susceptibility_to | 2.87293917 |
| 7 | MP0009764_decreased_sensitivity_to | 2.82242262 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.79309344 |
| 9 | MP0006082_CNS_inflammation | 2.78409948 |
| 10 | MP0002060_abnormal_skin_morphology | 2.74360065 |
| 11 | MP0003279_aneurysm | 2.67164506 |
| 12 | MP0005023_abnormal_wound_healing | 2.65403736 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.64869093 |
| 14 | MP0003303_peritoneal_inflammation | 2.58087076 |
| 15 | MP0002796_impaired_skin_barrier | 2.53766793 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.50415747 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 2.44063251 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.44063251 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.37562472 |
| 20 | MP0001853_heart_inflammation | 2.32173814 |
| 21 | MP0001958_emphysema | 2.27107336 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.21460319 |
| 23 | MP0003941_abnormal_skin_development | 2.19777887 |
| 24 | MP0009384_cardiac_valve_regurgitation | 2.18989969 |
| 25 | MP0002419_abnormal_innate_immunity | 2.18962709 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.16607613 |
| 27 | MP0005257_abnormal_intraocular_pressure | 2.15759935 |
| 28 | MP0001243_abnormal_dermal_layer | 2.15206671 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 2.13474138 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 2.12070267 |
| 31 | MP0002332_abnormal_exercise_endurance | 2.11765621 |
| 32 | MP0003075_altered_response_to | 2.04964979 |
| 33 | MP0009278_abnormal_bone_marrow | 2.02057557 |
| 34 | MP0003091_abnormal_cell_migration | 1.99805931 |
| 35 | MP0004272_abnormal_basement_membrane | 1.98712237 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.94024115 |
| 37 | MP0002006_tumorigenesis | 1.89885546 |
| 38 | MP0005025_abnormal_response_to | 1.85488835 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.84810474 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.83137649 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.83137515 |
| 42 | MP0005501_abnormal_skin_physiology | 1.80596598 |
| 43 | MP0005508_abnormal_skeleton_morphology | 1.77843013 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.75721329 |
| 45 | MP0006054_spinal_hemorrhage | 1.70424620 |
| 46 | MP0002723_abnormal_immune_serum | 1.69870530 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.65227048 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.63304156 |
| 49 | MP0004510_myositis | 1.61541531 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.60984863 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.59978183 |
| 52 | MP0001800_abnormal_humoral_immune | 1.59808445 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.59545363 |
| 54 | MP0009697_abnormal_copulation | 1.55083640 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.54868377 |
| 56 | MP0001542_abnormal_bone_strength | 1.54637649 |
| 57 | MP0005166_decreased_susceptibility_to | 1.54155529 |
| 58 | MP0003045_fibrosis | 1.53590346 |
| 59 | MP0009053_abnormal_anal_canal | 1.52783626 |
| 60 | MP0010771_integument_phenotype | 1.49186709 |
| 61 | * MP0010155_abnormal_intestine_physiology | 1.48771713 |
| 62 | MP0001790_abnormal_immune_system | 1.46763913 |
| 63 | MP0005387_immune_system_phenotype | 1.46763913 |
| 64 | MP0001216_abnormal_epidermal_layer | 1.44557102 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.44065671 |
| 66 | MP0008469_abnormal_protein_level | 1.42008817 |
| 67 | MP0002896_abnormal_bone_mineralization | 1.41997346 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 1.41685048 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.41519088 |
| 70 | MP0003724_increased_susceptibility_to | 1.41066472 |
| 71 | * MP0001845_abnormal_inflammatory_respons | 1.41061277 |
| 72 | MP0001819_abnormal_immune_cell | 1.39777528 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.39227587 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.38866946 |
| 75 | MP0002405_respiratory_system_inflammati | 1.36668094 |
| 76 | MP0002009_preneoplasia | 1.36203910 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.35169000 |
| 78 | MP0005390_skeleton_phenotype | 1.34466252 |
| 79 | MP0001299_abnormal_eye_distance/ | 1.33456695 |
| 80 | MP0002168_other_aberrant_phenotype | 1.30144359 |
| 81 | MP0000733_abnormal_muscle_development | 1.27774190 |
| 82 | MP0005666_abnormal_adipose_tissue | 1.25465754 |
| 83 | * MP0004947_skin_inflammation | 1.23898095 |
| 84 | MP0003436_decreased_susceptibility_to | 1.22150266 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 1.20842042 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.20425296 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.19708630 |
| 88 | MP0003385_abnormal_body_wall | 1.18081401 |
| 89 | MP0002933_joint_inflammation | 1.16023256 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.15644272 |
| 91 | MP0005671_abnormal_response_to | 1.15412052 |
| 92 | MP0008057_abnormal_DNA_replication | 1.12194645 |
| 93 | MP0001501_abnormal_sleep_pattern | 1.11917643 |
| 94 | MP0005451_abnormal_body_composition | 1.11680303 |
| 95 | MP0005076_abnormal_cell_differentiation | 1.11646814 |
| 96 | MP0000383_abnormal_hair_follicle | 1.11062548 |
| 97 | MP0005164_abnormal_response_to | 1.08193609 |
| 98 | MP0003195_calcinosis | 1.07439005 |
| 99 | MP0002998_abnormal_bone_remodeling | 1.07029143 |
| 100 | MP0000767_abnormal_smooth_muscle | 1.06738994 |
| 101 | MP0001851_eye_inflammation | 1.01278358 |
| 102 | MP0002282_abnormal_trachea_morphology | 1.00947173 |
| 103 | MP0000685_abnormal_immune_system | 1.00040060 |
| 104 | MP0000716_abnormal_immune_system | 0.99863606 |
| 105 | MP0001873_stomach_inflammation | 0.99171873 |
| 106 | MP0009763_increased_sensitivity_to | 0.95894689 |
| 107 | MP0002398_abnormal_bone_marrow | 0.95258689 |
| 108 | MP0005165_increased_susceptibility_to | 0.94479663 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.93913074 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.93171822 |
| 111 | MP0005266_abnormal_metabolism | 0.92254335 |
| 112 | MP0002113_abnormal_skeleton_development | 0.91960051 |
| 113 | MP0001191_abnormal_skin_condition | 0.90477437 |
| 114 | MP0003448_altered_tumor_morphology | 0.89440178 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.89329650 |
| 116 | MP0003942_abnormal_urinary_system | 0.89268676 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.89222564 |
| 118 | MP0000377_abnormal_hair_follicle | 0.89197122 |
| 119 | MP0003795_abnormal_bone_structure | 0.88649438 |
| 120 | MP0003828_pulmonary_edema | 0.87834893 |
| 121 | MP0000163_abnormal_cartilage_morphology | 0.87574046 |
| 122 | MP0003950_abnormal_plasma_membrane | 0.87403876 |
| 123 | MP0001881_abnormal_mammary_gland | 0.87266913 |
| 124 | MP0000627_abnormal_mammary_gland | 0.87208746 |
| 125 | MP0000858_altered_metastatic_potential | 0.86904947 |
| 126 | MP0002139_abnormal_hepatobiliary_system | 0.86674991 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.86365715 |
| 128 | MP0005535_abnormal_body_temperature | 0.85826272 |
| 129 | MP0000537_abnormal_urethra_morphology | 0.84943384 |
| 130 | MP0002115_abnormal_skeleton_extremities | 0.84820416 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.83578739 |
| 132 | MP0009931_abnormal_skin_appearance | 0.83180769 |
| 133 | MP0003755_abnormal_palate_morphology | 0.83149160 |
| 134 | MP0005647_abnormal_sex_gland | 0.82468812 |
| 135 | MP0002429_abnormal_blood_cell | 0.82256907 |
| 136 | MP0001177_atelectasis | 0.81150885 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.80371065 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.79901282 |
| 139 | MP0000343_altered_response_to | 0.79413481 |
| 140 | MP0010307_abnormal_tumor_latency | 0.77952059 |
| 141 | MP0003937_abnormal_limbs/digits/tail_de | 0.76373939 |
| 142 | MP0002177_abnormal_outer_ear | 0.76238914 |
| 143 | MP0002722_abnormal_immune_system | 0.75823190 |
| 144 | MP0004883_abnormal_blood_vessel | 0.75447029 |
| 145 | MP0009840_abnormal_foam_cell | 0.75292684 |
| 146 | MP0002138_abnormal_hepatobiliary_system | 0.75078740 |
| 147 | MP0009333_abnormal_splenocyte_physiolog | 0.74125326 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.73664479 |
| 149 | MP0005310_abnormal_salivary_gland | 0.72977372 |
| 150 | MP0000579_abnormal_nail_morphology | 0.72619578 |
| 151 | MP0000432_abnormal_head_morphology | 0.71752903 |
| 152 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71337912 |
| 153 | MP0005388_respiratory_system_phenotype | 0.70734721 |
| 154 | MP0002133_abnormal_respiratory_system | 0.70734721 |
| 155 | MP0001879_abnormal_lymphatic_vessel | 0.68633244 |
| 156 | MP0005197_abnormal_uvea_morphology | 0.68067200 |
| 157 | MP0000428_abnormal_craniofacial_morphol | 0.67148414 |
| 158 | MP0000427_abnormal_hair_cycle | 0.66146306 |
| 159 | MP0003115_abnormal_respiratory_system | 0.64668149 |
| 160 | MP0001614_abnormal_blood_vessel | 0.64526576 |
| 161 | MP0002128_abnormal_blood_circulation | 0.64356050 |
| 162 | MP0005395_other_phenotype | 0.64096573 |
| 163 | MP0000249_abnormal_blood_vessel | 0.62961481 |
| 164 | MP0002108_abnormal_muscle_morphology | 0.61998494 |
| 165 | MP0002148_abnormal_hypersensitivity_rea | 0.61865018 |
| 166 | MP0002098_abnormal_vibrissa_morphology | 0.60514649 |
| 167 | MP0001175_abnormal_lung_morphology | 0.57860086 |
| 168 | MP0010678_abnormal_skin_adnexa | 0.57555670 |
| 169 | MP0001340_abnormal_eyelid_morphology | 0.57344541 |
| 170 | MP0005375_adipose_tissue_phenotype | 0.57290776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 8.27837376 |
| 2 | Protrusio acetabuli (HP:0003179) | 7.01599667 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.20477544 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.20477544 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.20477544 |
| 6 | Atrophic scars (HP:0001075) | 5.03262488 |
| 7 | Peritonitis (HP:0002586) | 4.71595238 |
| 8 | Stomatitis (HP:0010280) | 4.62288050 |
| 9 | Aortic dissection (HP:0002647) | 4.56815782 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.27853944 |
| 11 | Shallow orbits (HP:0000586) | 4.19855333 |
| 12 | Fragile skin (HP:0001030) | 4.10710747 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 4.10467990 |
| 14 | Soft skin (HP:0000977) | 4.09009791 |
| 15 | Disinhibition (HP:0000734) | 4.03246626 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.00771458 |
| 17 | Optic neuritis (HP:0100653) | 4.00771458 |
| 18 | Dilatation of the ascending aorta (HP:0005111) | 3.79458455 |
| 19 | Orchitis (HP:0100796) | 3.76771891 |
| 20 | Myositis (HP:0100614) | 3.75631601 |
| 21 | Short nail (HP:0001799) | 3.74668294 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72632976 |
| 23 | Cervical subluxation (HP:0003308) | 3.69076399 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.63527904 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.54657175 |
| 26 | Genu recurvatum (HP:0002816) | 3.39102389 |
| 27 | Aortic aneurysm (HP:0004942) | 3.35635419 |
| 28 | Vertebral compression fractures (HP:0002953) | 3.33297463 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.29223227 |
| 30 | Abnormality of macrophages (HP:0004311) | 3.21210741 |
| 31 | Increased connective tissue (HP:0009025) | 3.18561992 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.14388084 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.14295227 |
| 34 | Acute lymphatic leukemia (HP:0006721) | 3.12091874 |
| 35 | Gangrene (HP:0100758) | 3.08976576 |
| 36 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.07928580 |
| 37 | Osteolytic defects of the hand bones (HP:0009699) | 3.07928580 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.97930914 |
| 39 | Abnormality of dentin (HP:0010299) | 2.97216775 |
| 40 | Neonatal short-limb short stature (HP:0008921) | 2.96163072 |
| 41 | Wormian bones (HP:0002645) | 2.91123078 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.88437019 |
| 43 | Vasculitis (HP:0002633) | 2.88408101 |
| 44 | Diaphragmatic weakness (HP:0009113) | 2.87031670 |
| 45 | Biconcave vertebral bodies (HP:0004586) | 2.84972796 |
| 46 | Parakeratosis (HP:0001036) | 2.81729693 |
| 47 | Loss of speech (HP:0002371) | 2.81523093 |
| 48 | Distal lower limb amyotrophy (HP:0008944) | 2.81149548 |
| 49 | Amyloidosis (HP:0011034) | 2.80942989 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80176422 |
| 51 | Increased density of long bones (HP:0006392) | 2.79668401 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.76768252 |
| 53 | Subacute progressive viral hepatitis (HP:0006572) | 2.74185167 |
| 54 | Ankle contracture (HP:0006466) | 2.72113986 |
| 55 | Syringomyelia (HP:0003396) | 2.71568468 |
| 56 | Spinal cord lesions (HP:0100561) | 2.71568468 |
| 57 | Coronal craniosynostosis (HP:0004440) | 2.71396896 |
| 58 | Increased serum ferritin (HP:0003281) | 2.68194178 |
| 59 | Blue sclerae (HP:0000592) | 2.67394426 |
| 60 | Spinal rigidity (HP:0003306) | 2.65713597 |
| 61 | Thin bony cortex (HP:0002753) | 2.64134528 |
| 62 | Wrist flexion contracture (HP:0001239) | 2.63226422 |
| 63 | Acute myeloid leukemia (HP:0004808) | 2.62519049 |
| 64 | Abnormal delivery (HP:0001787) | 2.60341360 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.59501303 |
| 66 | Bladder diverticulum (HP:0000015) | 2.58900595 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.56491251 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.53887170 |
| 69 | Recurrent viral infections (HP:0004429) | 2.53286802 |
| 70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.46479164 |
| 71 | Mutism (HP:0002300) | 2.44355842 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.43534936 |
| 73 | Tibial bowing (HP:0002982) | 2.43443338 |
| 74 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.41508072 |
| 75 | Progressive external ophthalmoplegia (HP:0000590) | 2.41489416 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.41235227 |
| 77 | B lymphocytopenia (HP:0010976) | 2.37402221 |
| 78 | Aplasia involving bones of the extremities (HP:0009825) | 2.35331972 |
| 79 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.35331972 |
| 80 | Aplasia of the phalanges of the hand (HP:0009802) | 2.35331972 |
| 81 | Fused cervical vertebrae (HP:0002949) | 2.35161852 |
| 82 | Myocardial infarction (HP:0001658) | 2.34850721 |
| 83 | Natal tooth (HP:0000695) | 2.34335394 |
| 84 | Inappropriate behavior (HP:0000719) | 2.33358695 |
| 85 | Nausea (HP:0002018) | 2.33234010 |
| 86 | Viral hepatitis (HP:0006562) | 2.32637926 |
| 87 | Alopecia of scalp (HP:0002293) | 2.31626011 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.31305424 |
| 89 | Right ventricular cardiomyopathy (HP:0011663) | 2.30795579 |
| 90 | Hematochezia (HP:0002573) | 2.29771844 |
| 91 | Choroideremia (HP:0001139) | 2.29332696 |
| 92 | Hyperextensible skin (HP:0000974) | 2.26986079 |
| 93 | Elbow flexion contracture (HP:0002987) | 2.25625430 |
| 94 | Broad metatarsal (HP:0001783) | 2.24647011 |
| 95 | Broad face (HP:0000283) | 2.22149880 |
| 96 | Mesomelia (HP:0003027) | 2.21846976 |
| 97 | Overgrowth (HP:0001548) | 2.20709097 |
| 98 | Spinal cord compression (HP:0002176) | 2.20022236 |
| 99 | Distal lower limb muscle weakness (HP:0009053) | 2.19247546 |
| 100 | Follicular hyperkeratosis (HP:0007502) | 2.19053538 |
| 101 | Mitral regurgitation (HP:0001653) | 2.16120744 |
| 102 | Cardiovascular calcification (HP:0011915) | 2.15800798 |
| 103 | Nuclear cataract (HP:0100018) | 2.15443068 |
| 104 | Alveolar cell carcinoma (HP:0006519) | 2.10678082 |
| 105 | Thrombocytosis (HP:0001894) | 2.10437398 |
| 106 | Increased mean platelet volume (HP:0011877) | 2.08862217 |
| 107 | Infantile muscular hypotonia (HP:0008947) | 2.08408803 |
| 108 | Arterial thrombosis (HP:0004420) | 2.07882901 |
| 109 | Hemoptysis (HP:0002105) | 2.07704874 |
| 110 | Polyneuropathy (HP:0001271) | 2.07499771 |
| 111 | Bronchomalacia (HP:0002780) | 2.06481548 |
| 112 | Amaurosis fugax (HP:0100576) | 2.06025874 |
| 113 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05451155 |
| 114 | Prostate neoplasm (HP:0100787) | 2.05287420 |
| 115 | Deviation of the hallux (HP:0010051) | 2.05278684 |
| 116 | Radial bowing (HP:0002986) | 2.04779067 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 2.04612058 |
| 118 | Achilles tendon contracture (HP:0001771) | 2.04599849 |
| 119 | Abnormality of the acetabulum (HP:0003170) | 2.04012873 |
| 120 | Posterior subcapsular cataract (HP:0007787) | 2.03749728 |
| 121 | Erythroderma (HP:0001019) | 2.02546894 |
| 122 | Scapular winging (HP:0003691) | 2.02395658 |
| 123 | Abnormal blistering of the skin (HP:0008066) | 2.01409086 |
| 124 | Lower limb amyotrophy (HP:0007210) | 2.00872609 |
| 125 | Vascular tortuosity (HP:0004948) | 2.00546430 |
| 126 | Onycholysis (HP:0001806) | 1.98478392 |
| 127 | Neurofibrillary tangles (HP:0002185) | 1.98092649 |
| 128 | Hallux valgus (HP:0001822) | 1.97897516 |
| 129 | Leukocytosis (HP:0001974) | 1.97413120 |
| 130 | Difficulty climbing stairs (HP:0003551) | 1.97365666 |
| 131 | Erythema (HP:0010783) | 1.96867507 |
| 132 | Venous abnormality (HP:0002624) | 1.96809315 |
| 133 | Anorexia (HP:0002039) | 1.96222029 |
| 134 | Bell-shaped thorax (HP:0001591) | 1.95676842 |
| 135 | Fibular aplasia (HP:0002990) | 1.95495456 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.94733855 |
| 137 | Fragile nails (HP:0001808) | 1.94170067 |
| 138 | Glomerulopathy (HP:0100820) | 1.93511518 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.93313940 |
| 140 | Round ear (HP:0100830) | 1.92450906 |
| 141 | Camptodactyly of toe (HP:0001836) | 1.92048291 |
| 142 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91252771 |
| 143 | Abnormality of the calcaneus (HP:0008364) | 1.90998029 |
| 144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90870920 |
| 145 | Joint swelling (HP:0001386) | 1.90268995 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.89713306 |
| 147 | Increased IgM level (HP:0003496) | 1.88177803 |
| 148 | Urticaria (HP:0001025) | 1.88058263 |
| 149 | Apathy (HP:0000741) | 1.87901986 |
| 150 | Pustule (HP:0200039) | 1.87215447 |
| 151 | Femoral bowing (HP:0002980) | 1.87103571 |
| 152 | Thick nail (HP:0001805) | 1.85348909 |
| 153 | Petechiae (HP:0000967) | 1.84726951 |
| 154 | Arthralgia (HP:0002829) | 1.83842449 |
| 155 | Aneurysm (HP:0002617) | 1.83510377 |
| 156 | Bowel diverticulosis (HP:0005222) | 1.83346187 |
| 157 | Fatigue (HP:0012378) | 1.82757703 |
| 158 | Abnormality of the 2nd finger (HP:0004100) | 1.81721617 |
| 159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81029277 |
| 160 | Plantar hyperkeratosis (HP:0007556) | 1.80652569 |
| 161 | Diminished motivation (HP:0000745) | 1.79598413 |
| 162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79398753 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79307172 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79307172 |
| 165 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79307172 |
| 166 | Hepatosplenomegaly (HP:0001433) | 1.79051171 |
| 167 | Abnormality of the Achilles tendon (HP:0005109) | 1.79042329 |
| 168 | Recurrent skin infections (HP:0001581) | 1.78408328 |
| 169 | Abnormality of the umbilical cord (HP:0010881) | 1.78186185 |
| 170 | Somatic mutation (HP:0001428) | 1.77977769 |
| 171 | Wide anterior fontanel (HP:0000260) | 1.77508763 |
| 172 | Micronodular cirrhosis (HP:0001413) | 1.77409306 |
| 173 | Recurrent fungal infections (HP:0002841) | 1.77382295 |
| 174 | Abnormal platelet volume (HP:0011876) | 1.77089234 |
| 175 | Coxa vara (HP:0002812) | 1.76798413 |
| 176 | Upper limb muscle weakness (HP:0003484) | 1.76463969 |
| 177 | Oral leukoplakia (HP:0002745) | 1.76283034 |
| 178 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.75802195 |
| 179 | Flat occiput (HP:0005469) | 1.74540443 |
| 180 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.74325082 |
| 181 | Thoracolumbar scoliosis (HP:0002944) | 1.73410929 |
| 182 | Abnormality of the basal ganglia (HP:0002134) | 1.73341021 |
| 183 | Impaired platelet aggregation (HP:0003540) | 1.73305363 |
| 184 | Abnormal platelet function (HP:0011869) | 1.73305363 |
| 185 | Eosinophilia (HP:0001880) | 1.72974388 |
| 186 | Microglossia (HP:0000171) | 1.72550170 |
| 187 | Cheilitis (HP:0100825) | 1.72545153 |
| 188 | Insomnia (HP:0100785) | 1.72336424 |
| 189 | Thin skin (HP:0000963) | 1.70205183 |
| 190 | Decreased skull ossification (HP:0004331) | 1.68992928 |
| 191 | Bowed forearm bones (HP:0003956) | 1.68985924 |
| 192 | Bowing of the arm (HP:0006488) | 1.68985924 |
| 193 | Milia (HP:0001056) | 1.68669838 |
| 194 | Asymmetry of the thorax (HP:0001555) | 1.67307062 |
| 195 | Abnormality of the nasal septum (HP:0000419) | 1.66142695 |
| 196 | Persistence of primary teeth (HP:0006335) | 1.66081367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.96390702 |
| 2 | EPHA2 | 4.27961614 |
| 3 | DDR2 | 3.94757700 |
| 4 | TTN | 3.76359620 |
| 5 | BMPR2 | 3.26670826 |
| 6 | FER | 3.16317602 |
| 7 | LATS1 | 3.03894774 |
| 8 | TRIB3 | 2.95047821 |
| 9 | EPHB2 | 2.67572651 |
| 10 | PKN2 | 2.42849839 |
| 11 | PDGFRA | 2.35874894 |
| 12 | TRPM7 | 2.32333493 |
| 13 | PIM2 | 2.27644375 |
| 14 | GRK7 | 2.09105699 |
| 15 | STK39 | 2.07492265 |
| 16 | TAOK2 | 2.05607876 |
| 17 | TESK1 | 2.05379899 |
| 18 | BMX | 1.99152355 |
| 19 | EIF2AK3 | 1.98886650 |
| 20 | LIMK1 | 1.89022828 |
| 21 | TAOK3 | 1.87290345 |
| 22 | LRRK2 | 1.86194638 |
| 23 | RPS6KA4 | 1.83270330 |
| 24 | STK3 | 1.76234830 |
| 25 | PAK2 | 1.72871718 |
| 26 | LATS2 | 1.71168671 |
| 27 | PTK2 | 1.70132014 |
| 28 | MST1R | 1.65685699 |
| 29 | NEK9 | 1.63263264 |
| 30 | MOS | 1.61378234 |
| 31 | NME2 | 1.59282600 |
| 32 | ERBB3 | 1.59013992 |
| 33 | RIPK1 | 1.55677790 |
| 34 | SIK3 | 1.50528041 |
| 35 | MATK | 1.49502569 |
| 36 | PIK3CG | 1.41061453 |
| 37 | FRK | 1.38316860 |
| 38 | ERN1 | 1.37763711 |
| 39 | IKBKE | 1.37267788 |
| 40 | PAK4 | 1.37254092 |
| 41 | MAP3K14 | 1.36904053 |
| 42 | WNK4 | 1.35820181 |
| 43 | PAK3 | 1.35391782 |
| 44 | TNIK | 1.30325195 |
| 45 | PTK6 | 1.30312020 |
| 46 | MAP3K3 | 1.28893329 |
| 47 | PRPF4B | 1.24500441 |
| 48 | STK10 | 1.23499723 |
| 49 | DMPK | 1.23422539 |
| 50 | MKNK1 | 1.15174405 |
| 51 | CSK | 1.13922472 |
| 52 | IRAK4 | 1.11590165 |
| 53 | MET | 1.11110228 |
| 54 | FGFR1 | 1.05362990 |
| 55 | FGR | 1.03280002 |
| 56 | CDK6 | 1.02775609 |
| 57 | CSF1R | 1.02663509 |
| 58 | PDGFRB | 1.00333428 |
| 59 | ERBB4 | 1.00040023 |
| 60 | TEC | 0.97703391 |
| 61 | TXK | 0.95253855 |
| 62 | ABL2 | 0.94964280 |
| 63 | JAK3 | 0.90511542 |
| 64 | EPHA3 | 0.89317106 |
| 65 | PIK3CA | 0.87683088 |
| 66 | MAP2K1 | 0.87351924 |
| 67 | TBK1 | 0.86592410 |
| 68 | MST4 | 0.83771440 |
| 69 | ADRBK2 | 0.83535456 |
| 70 | TESK2 | 0.79517471 |
| 71 | MAP3K5 | 0.78660599 |
| 72 | SCYL2 | 0.78365590 |
| 73 | TRIM28 | 0.77695210 |
| 74 | MAP2K3 | 0.75778466 |
| 75 | MAPKAPK3 | 0.75685511 |
| 76 | PTK2B | 0.74811610 |
| 77 | ROCK1 | 0.74032312 |
| 78 | MAP3K11 | 0.73967593 |
| 79 | INSR | 0.71204525 |
| 80 | PLK4 | 0.70365660 |
| 81 | STK38L | 0.68404092 |
| 82 | IKBKB | 0.66832534 |
| 83 | MKNK2 | 0.65797955 |
| 84 | MAP3K8 | 0.64895821 |
| 85 | TLK1 | 0.63827723 |
| 86 | JAK1 | 0.63595461 |
| 87 | PLK2 | 0.61355962 |
| 88 | DYRK1B | 0.60661431 |
| 89 | KIT | 0.59811308 |
| 90 | BLK | 0.59021102 |
| 91 | PRKG2 | 0.58465029 |
| 92 | ADRBK1 | 0.58348711 |
| 93 | IRAK1 | 0.55205710 |
| 94 | RPS6KB2 | 0.53727852 |
| 95 | NUAK1 | 0.52902331 |
| 96 | MAPKAPK5 | 0.51919028 |
| 97 | HCK | 0.51885269 |
| 98 | EPHB1 | 0.51848600 |
| 99 | TGFBR2 | 0.50921158 |
| 100 | ABL1 | 0.50812434 |
| 101 | CCNB1 | 0.50423229 |
| 102 | PRKD2 | 0.50098415 |
| 103 | IRAK2 | 0.48487055 |
| 104 | DAPK3 | 0.47977645 |
| 105 | CDK9 | 0.47782125 |
| 106 | ZAK | 0.47724989 |
| 107 | ILK | 0.47471616 |
| 108 | NEK2 | 0.47130210 |
| 109 | STK24 | 0.46755581 |
| 110 | ACVR1B | 0.46600602 |
| 111 | TYK2 | 0.46440175 |
| 112 | BRD4 | 0.45720372 |
| 113 | FES | 0.45248870 |
| 114 | ERBB2 | 0.44228059 |
| 115 | PDK2 | 0.43046990 |
| 116 | EGFR | 0.42869800 |
| 117 | EIF2AK1 | 0.42698801 |
| 118 | MELK | 0.41622161 |
| 119 | MTOR | 0.40724494 |
| 120 | CSNK1A1L | 0.38655448 |
| 121 | TIE1 | 0.38177720 |
| 122 | MAP3K1 | 0.38146913 |
| 123 | PBK | 0.38123099 |
| 124 | MAP3K2 | 0.37443961 |
| 125 | MAPKAPK2 | 0.36840241 |
| 126 | TGFBR1 | 0.36579117 |
| 127 | PRKCQ | 0.36227553 |
| 128 | MAP3K12 | 0.36058347 |
| 129 | PRKCE | 0.34974597 |
| 130 | MAP3K13 | 0.34313753 |
| 131 | FLT3 | 0.34297343 |
| 132 | TAOK1 | 0.33568730 |
| 133 | CHUK | 0.33297403 |
| 134 | SRC | 0.33210273 |
| 135 | GSK3A | 0.32999532 |
| 136 | EEF2K | 0.32631173 |
| 137 | CDK8 | 0.32354806 |
| 138 | EIF2AK2 | 0.32332375 |
| 139 | ALK | 0.32269314 |
| 140 | BCR | 0.31765391 |
| 141 | ROCK2 | 0.31079853 |
| 142 | CAMK2D | 0.30476832 |
| 143 | IGF1R | 0.30256632 |
| 144 | SIK1 | 0.28140361 |
| 145 | LYN | 0.28009111 |
| 146 | JAK2 | 0.27054450 |
| 147 | RIPK4 | 0.23897120 |
| 148 | BMPR1B | 0.23889290 |
| 149 | MARK3 | 0.22761269 |
| 150 | HIPK2 | 0.20557339 |
| 151 | MAP2K6 | 0.19912622 |
| 152 | LCK | 0.18693329 |
| 153 | CLK1 | 0.18332514 |
| 154 | WNK1 | 0.17481742 |
| 155 | CHEK2 | 0.16977675 |
| 156 | PIM1 | 0.16934805 |
| 157 | BRSK2 | 0.16800358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 3.29560553 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.24298565 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.22880640 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55205062 |
| 5 | Bladder cancer_Homo sapiens_hsa05219 | 2.51584318 |
| 6 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.38907232 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 2.32931845 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.27941342 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.25385886 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.23323728 |
| 11 | Amoebiasis_Homo sapiens_hsa05146 | 2.14861601 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.05489434 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.97799679 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.97632521 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91509114 |
| 16 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.91241323 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89874805 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.87928286 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87845119 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.87694482 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82949586 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.82945584 |
| 23 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.75041411 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.73621624 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.72827197 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.68505067 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68437340 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.67728276 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60895727 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.54523635 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54155273 |
| 32 | Melanoma_Homo sapiens_hsa05218 | 1.53955228 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.51721409 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51430014 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.46959466 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.44984669 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43825539 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41458088 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.40850477 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38987496 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.36978242 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.32944295 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29566467 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.25931938 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 1.23228119 |
| 46 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.23138298 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21737462 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16093653 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11655702 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07899161 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.07623085 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06259120 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 1.03542217 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02390208 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02054683 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 1.01896539 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01772576 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01076756 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99056643 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.97872240 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97771869 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96916522 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94073434 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94059934 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92184903 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.87779197 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87454542 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85796527 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84709874 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84128241 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83750649 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83624263 |
| 73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.82742924 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.80685072 |
| 75 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80539470 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78781949 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.78006170 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77503462 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76667152 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76568446 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76544736 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75451530 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72288613 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.70885526 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66463239 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66090813 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65303290 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64635982 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64436409 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63155149 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62752203 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62032739 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60522153 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60452746 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60088372 |
| 96 | Axon guidance_Homo sapiens_hsa04360 | 0.59526156 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58808658 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57670397 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57347585 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55788793 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53449225 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52494728 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52192574 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50820045 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50697572 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49824375 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.46961889 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46791025 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.46136744 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46041722 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43627412 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.43594809 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42704396 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42144659 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41943805 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.41188945 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41096652 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.40172202 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40039523 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39203209 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37853193 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37344423 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37105587 |
| 124 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37050670 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36733471 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.36104306 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.36081332 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35186695 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34796077 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31718834 |
| 131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29873371 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27548419 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27068575 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26342049 |
| 135 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.22727166 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21609728 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19134119 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.18740345 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.17063851 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12065787 |
| 141 | RNA degradation_Homo sapiens_hsa03018 | 0.11927087 |

